Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,893 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N. Nakaoka Y, et al. Among authors: yoshida s. Ann Rheum Dis. 2018 Mar;77(3):348-354. doi: 10.1136/annrheumdis-2017-211878. Epub 2017 Nov 30. Ann Rheum Dis. 2018. PMID: 29191819 Free PMC article. Clinical Trial.
A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia.
Hirayasu Y, Sato S, Takahashi H, Iida S, Shuto N, Yoshida S, Funatogawa T, Yamada T, Higuchi T. Hirayasu Y, et al. Among authors: yoshida s. BMC Psychiatry. 2016 Mar 15;16:66. doi: 10.1186/s12888-016-0778-9. BMC Psychiatry. 2016. PMID: 26980460 Free PMC article. Clinical Trial.
AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab - protocol for a multicentre, open-label, phase IV clinical study.
Shima M, Takedani H, Kitsukawa K, Taki M, Ishiguro A, Nagao A, Yamaguchi-Suita H, Kyogoku Y, Yoshida S, Nogami K. Shima M, et al. Among authors: yoshida s. BMJ Open. 2022 Jun 13;12(6):e059667. doi: 10.1136/bmjopen-2021-059667. BMJ Open. 2022. PMID: 35697445 Free PMC article.
Challenges on Multiple Endpoints in Clinical Trials: An Industry Survey in Japan.
Sakamaki K, Yoshida S, Morita Y, Kamiura T, Iba K, Ogawa N, Suganami H, Tsuchiya S, Fukimbara S. Sakamaki K, et al. Among authors: yoshida s. Ther Innov Regul Sci. 2019 Jun 18:2168479019855994. doi: 10.1177/2168479019855994. Online ahead of print. Ther Innov Regul Sci. 2019. PMID: 31213076
7,893 results